端锚聚合酶抑制剂XAV939抑制人骨肉瘤SOSP-9607细胞增殖及作用机制研究
x

请在关注微信后,向客服人员索取文件

篇名: 端锚聚合酶抑制剂XAV939抑制人骨肉瘤SOSP-9607细胞增殖及作用机制研究
TITLE:
摘要: 目的:研究端锚聚合酶抑制剂XAV939对人骨肉瘤SOSP-9607细胞增殖的抑制及其作用机制。方法:以人骨肉瘤SOSP-9607细胞为研究对象,采用CCK-8法测定0.5、1、5、10 μmol/L XAV939分别作用24、48、72 h后的细胞增殖情况,并计算细胞抑制率;采用流式细胞术检测5 μmol/L XAV939作用72 h后的细胞凋亡情况及周期分布;以甘油醛-3-硫酸脱氢酶(GAPDH)为内参,采用蛋白质印迹法测定0.5、1、5、10 μmol/L XAV939作用72 h后细胞中β-联蛋白(β-catenin)、G1/S期特异性周期蛋白D1(Cyclin D1)和基质金属蛋白酶7(MMP-7)的相对表达量。结果:1 μmol/L XAV939作用72 h后,5、10 μmol/L XAV939作用24、48、72 h后,SOSP-9607细胞的抑制率均显著升高(P<0.05或P<0.01)。5 μmol/L XAV939作用72 h后,SOSP-9607细胞的凋亡率从3.71%上升至21.03%(P<0.05);G1期细胞的比例由45.5%增至54.8%,S期细胞的比例由27.4%降至24.0%,G2/M期细胞的比例由22.2%降至16.2%(P<0.05)。5、10 μmol/L XAV939作用72 h后,SOSP-9607细胞中β-catenin、Cyclin D1和MMP-7的相对表达量均显著下降(P<0.05或P<0.01)。结论:端锚聚合酶抑制剂XAV939能够抑制人骨肉瘤SOSP-9607细胞的增殖,其机制可能与其将细胞周期阻滞于G1期、阻断细胞外因子(Wnt)/β-catenin信号通路有关。
ABSTRACT: OBJECTIVE: To study the inhibitory effect of tankyrase inhibitor XAV939 on human osteosarcoma SOSP-9607 cells and its mechanism. METHODS: The human osteosarcoma SOSP-9607 cells were selected as research objects. The proliferation of osteosarcoma cells was determined by CCK-8 method after treated with 0.5, 1, 5, 10 μmol/L XAV939 for 24, 48, 72 h, and the inhibitory rate was calculated. After treated with 5 μmol/L XAV939 for 72 h, flow cytometry was applied to detect cell apoptosis and cell cycle distribution of osteosarcoma cells. Using glyceraldehyde-3-dehydrogenase (GAPDH) as internal reference, Western blot assay was used to detect the relative expression of β-catenin, Cyclin D1 and MMP-7 in osteosarcoma cells after treated with 0.5, 1, 5, 10 μmol/L XAV939 for 72 h. RESULTS: After treated with 1 μmol/L XAV939 for 72 h, 5, 10 μmol/L XAV939 for 24, 48, 72 h, the inhibitory rates of SOSP-9607 cells were increased significantly (P<0.05 or P<0.01). After treated with 5 μmol/L XAV939 for 72 h, the apoptotic rate of SOSP-9607 cells was increased from 3.71% to 21.03% (P<0.05); the proportion of G1-phase cells increased from 45.5% to 54.8%, that of S-phase cells decreased from 27.4% to 24.0%, that of G2/M-phase cells decreased from 22.2% to 16.2% (P<0.05). After treated with 5, 10 μmol/L XAV939 for 72 h, the relative expression of β-catenin, Cyclin D1 and MMP-7 in SOSP-9607 cells decreased significantly(P<0.05 or P<0.01). CONCLUSIONS: Tankyrase inhibitor XAV939 can inhibit the proliferation of human osteosarcoma SOSP-9607 cells, the mechanism of which may be associated with arresting cells at G1 phase and blocking signaling pathway of Wnt/β-catenin.
期刊: 2018年第29卷第14期
作者: 董永红,彭雯,王耀华,张丽艳
AUTHORS: DONG Yonghong,PENG Wen,WANG Yaohua,ZHANG Liyan
关键字: 人骨肉瘤SOSP-9607细胞;端锚聚合酶抑制剂;XAV939;细胞外因子/β-联蛋白信号通路;增殖;凋亡
KEYWORDS: Human osteosarcoma SOSP-9607 cells; Tankyrase inhibitor; XAV939; Wnt/β-catenin signaling pathway; Proliferation; Apoptosis
阅读数: 365 次
本月下载数: 4 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!